Understanding persistent breathlessness: impact on patients and optimal approaches to symptomatic reduction – an overview

References

• Johnson MJ, Yorke J, Hansen-Flaschen J, et al. Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness. Eur Respir J. 2017;49(5):1602277.
   PubMed Web of Science ®Google Scholar
• Currow DC, Plummer JL, Crockett A, et al. A community population survey of prevalence and severity of dyspnea in adults. J Pain Symptom Manage. 2009 Oct;38(4):533–545.
   PubMed Web of Science ®Google Scholar
• Moens K, Higginson IJ, Harding R, et al. Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review. J Pain Symptom Manage. 2014;48(4):660–677.
   PubMed Web of Science ®Google Scholar
• Guo YL, Ampon MR, Poulos LM, et al. Contribution of obesity to breathlessness in a large nationally representative sample of Australian adults. Respirology. 2022;28:350–356.
   PubMed Web of Science ®Google Scholar
• Reuben DB, Mor V. Dyspnea in terminally ill cancer patients. Chest. 1986 Feb;89(2):234–236.
   PubMed Web of Science ®Google Scholar
• McCarthy M, Lay M, Addington-Hall J. Dying from heart disease. J R Coll Physicians Lond. 1996 Jul;30(4):325–328.
   PubMedGoogle Scholar
• Currow DC, Smith J, Davidson PM, et al. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Symptom Manage. 2010 Apr;39(4):680–690.
   PubMed Web of Science ®Google Scholar
• Currow DC, Smith JM, Chansriwong P, et al. Missed opportunity? Worsening breathlessness as a harbinger of death. A cohort study. Eur Respir J. 2018;52:1800684.
   PubMed Web of Science ®Google Scholar
• Johnson MJ, Bowden JA, Abernethy AP, et al. To what causes do people attribute their chronic breathlessness? A population survey. J Palliat Med. 2012;15(7):744–750.
   PubMed Web of Science ®Google Scholar
• Tod AM, Joanne R. Overcoming delay in the diagnosis of lung cancer: a qualitative study. Nurs Stand. 2010 Apr 7-13;24(31):35–43.
   Google Scholar
• Abernethy AP, Wheeler JL. Total dyspnoea. Curr Opin Support Palliat Care. 2008;2(2):110–113.
   PubMedGoogle Scholar
• Kamal AH, Maguire JM, Wheeler JL, et al. Dyspnea review for the palliative care professional: assessment, burdens, and etiologies. J Palliat Med. 2011 Oct;14(10):1167–1172.
   PubMed Web of Science ®Google Scholar
• Williams M, Cafarella P, Olds T, et al. The language of breathlessness differentiates between patients with COPD and age-matched adults. Chest J. 2008;134(3):489–496.
   PubMed Web of Science ®Google Scholar
• Gorini M, Misuri G, Corrado A, et al. Breathing pattern and carbon dioxide retention in severe chronic obstructive pulmonary disease. Thorax. 1996 Jul;51(7):677–683.
   PubMed Web of Science ®Google Scholar
• Ramon MA, Ter Riet G, Carsin AE, et al. The dyspnoea-inactivity vicious circle in COPD: development and external validation of a conceptual model. Eur Respir J. 2018 Sep;52(3):1800079.
   PubMed Web of Science ®Google Scholar
• Nicholls DA. The experience of chronic breathlessness. Physiother Theory Pract. 2003;19(3):123–136.
   Google Scholar
• Barnett M. Chronic obstructive pulmonary disease: a phenomenological study of patients’ experiences. J Clin Nurs. 2005;14(7):805–812.
   PubMed Web of Science ®Google Scholar
• Gysels M, Bausewein C, Higginson IJ. Experiences of breathlessness: a systematic review of the qualitative literature. Palliat Support Care. 2007;5(3):281–302.
   PubMedGoogle Scholar
• Ahmadi NS, Mansson J, Lindblad U, et al. Breathlessness in everyday life from a patient perspective: a qualitative study using diaries. Palliat Support Care. 2014 Jun;12(3):189–194.
   PubMed Web of Science ®Google Scholar
• Paap MC, Bode C, Lenferink LI, et al. Identifying key domains of health-related quality of life for patients with chronic obstructive pulmonary disease: the patient perspective. Health Qual Life Outcomes. 2014 Jul 9;12:106.
   PubMed Web of Science ®Google Scholar
• Lowey SE, Powers BA, Xue Y. Short of breath and dying: state of the science on opioid agents for the palliation of refractory dyspnea in older adults. J Gerontol Nurs. 2013 Feb;39(2):43–52.
   PubMed Web of Science ®Google Scholar
• Gysels MH, Higginson IJ. Caring for a person in advanced illness and suffering from breathlessness at home: threats and resources. Palliat Support Care. 2009;7(2):153–162.
   PubMedGoogle Scholar
• Bergs D. “The Hidden Client”–women caring for husbands with COPD: their experience of quality of life. J Clin Nurs. 2002 Sep;11(5):613–621.
   PubMed Web of Science ®Google Scholar
• Simpson AC, Young J, Donahue M, et al. A day at a time: caregiving on the edge in advanced COPD. Int J Chron Obstruct Pulmon Dis. 2010;5:141.
   PubMedGoogle Scholar
• Currow DC, Dal Grande E, Ferreira DH, et al. Chronic breathlessness associated with poorer physical and mental health-related quality of life (SF-12) across all adult age groups. Thorax. 2017;72(12):1151–1153.
   PubMed Web of Science ®Google Scholar
• Currow DC, Chang S, Reddel HK, et al. Breathlessness, anxiety, depression, and function-the bad-f study: a cross-sectional and population prevalence study in adults. J Pain Symptom Manage. 2020 Feb;59(2):197–205 e2.
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Willgoss TG, Baldwin RC, et al. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010 Dec;25(12):1209–1221.
   PubMed Web of Science ®Google Scholar
• Ng TP, Niti M, Tan WC, et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007 Jan 8;167(1):60–67.
   PubMedGoogle Scholar
• McLaughlin‐barrett S, Brunelli VN. Did you smoke? Addressing stigma in lung cancer. Respirology. 2021;26(11):1018–1020.
   PubMed Web of Science ®Google Scholar
• Gurung R, Sarason B, Sarason I. Close personal relationships and health outcomes: a key to the role of social support. In: Duck S, editor. Handbook of personal relationships: theory, research and interventions. 2nd ed. Chichester (UK): Wiley; 1997. p. 547–573.
   Google Scholar
• Cohen S. Social relationships and health. American Psychologist. 2004;59(8):676.
   PubMed Web of Science ®Google Scholar
• Boyle AH. Living with a spouse with chronic obstructive pulmonary disease: the meaning of wives’ experiences. J Nurs Healthcare Chronic Illness. 2009;1(4):273–282.
   Google Scholar
• Ekstrom M, Johnson MJ, Taylor B, et al. Breathlessness and sexual activity in older adults: the Australian Longitudinal Study of Ageing. NPJ Prim Care Respir Med. 2018 Jun 22;28(1):20.
   PubMedGoogle Scholar
• Ek K, Sahlberg-Blom E, Andershed B, et al. Struggling to retain living space: patients’ stories about living with advanced chronic obstructive pulmonary disease. J Adv Nurs. 2011 Jul;67(7):1480–1490.
   PubMed Web of Science ®Google Scholar
• Holt-Lunstad J, Smith TB, Baker M, et al. Loneliness and social isolation as risk factors for mortality: a meta-analytic review. Perspectives Psychol Sci. 2015;10(2):227–237.
   PubMed Web of Science ®Google Scholar
• Nicolson P, Anderson P. Quality of life, distress and self-esteem: a focus group study of people with chronic bronchitis. Br J Health Psychol. 2003 Sep;8(Pt 3):251–270.
   PubMedGoogle Scholar
• Seamark DA, Blake SD, Seamark CJ, et al. Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers. An interpretative phenomenological analysis. Palliat Med. 2004 Oct;18(7):619–625.
   PubMed Web of Science ®Google Scholar
• Bolton LE, Seymour J, Gardiner C. Existential suffering in the day to day lives of those living with palliative care needs arising from chronic obstructive pulmonary disease (COPD): a systematic integrative literature review. Palliat Med. 2022;36(4):567–580.
   PubMed Web of Science ®Google Scholar
• Jonsdottir H. Life patterns of people with chronic obstructive pulmonary disease: isolation and being closed in. Nurs Sci Q. 1998;11(4):160–166.
   PubMed Web of Science ®Google Scholar
• Gardiner C, Gott M, Small N, et al. Living with advanced chronic obstructive pulmonary disease: patients concerns regarding death and dying. Palliat Med. 2009 Dec;23(8):691–697.
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Banzett RB, Carrieri-Kohlman V, et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc. 2007 May;4(2):145–168.
   PubMedGoogle Scholar
• Neder JA. Residual exertional dyspnea in cardiopulmonary disease. Ann Am Thorac Soc. 2020 Dec;17(12):1516–1525.
   PubMed Web of Science ®Google Scholar
• Davenport PW, Vovk A. Cortical and subcortical central neural pathways in respiratory sensations. Respir Physiol Neurobiol. 2009 May 30;167(1):72–86.
   PubMed Web of Science ®Google Scholar
• von Leupoldt A, Taube K, Schubert-Heukeshoven S, et al. Distractive auditory stimuli reduce the unpleasantness of dyspnea during exercise in patients with COPD. Chest. 2007;132(5):1506–1512.
   PubMed Web of Science ®Google Scholar
• Pattinson KT, Johnson MJ. Neuroimaging of central breathlessness mechanisms. Curr Opin Support Palliat Care. 2014 Sep;8(3):225–233.
   PubMed Web of Science ®Google Scholar
• Marlow LL, Faull OK, Finnegan SL, et al. Breathlessness and the brain: the role of expectation. Curr Opin Support Palliat Care. 2019 Sep;13(3):200–210.
   PubMed Web of Science ®Google Scholar
• Rietveld S, Kolk AM, Prins PJ, et al. The influence of respiratory sounds on breathlessness in children with asthma: a symptom-perception approach. Health Psychol. 1997 Nov;16(6):547–553.
   PubMed Web of Science ®Google Scholar
• Smith AK, Currow DC, Abernethy AP, et al. Prevalence and outcomes of breathlessness in older adults: a national population study. J Am Geriatr Soc. 2016 Oct;64(10):2035–2041.
   PubMed Web of Science ®Google Scholar
• Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002 May;121(5):1434–1440.
   PubMed Web of Science ®Google Scholar
• Vigano A, Donaldson N, Higginson IJ, et al. Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer. 2004 Sep 1;101(5):1090–1098.
   PubMed Web of Science ®Google Scholar
• Barlera S, Tavazzi L, Franzosi MG, et al. Predictors of mortality in 6975 patients with chronic heart failure in the gruppo italiano per lo studio della streptochinasi nell’infarto miocardico-heart failure trial: proposal for a nomogram. Circ Heart Fail. 2013 Jan;6(1):31–39.
   PubMed Web of Science ®Google Scholar
• Skilbeck J, Mott L, Page H, et al. Palliative care in chronic obstructive airways disease: a needs assessment. Palliat Med. 1998;12(4):245–254.
   PubMed Web of Science ®Google Scholar
• Wallace EM, Cooney MC, Walsh J, et al. Why do palliative care patients present to the emergency department? Avoidable or unavoidable? Am J Hospice Palliative Med®. 2013;30(3):253–256.
   PubMed Web of Science ®Google Scholar
• Langlo NM, Orvik AB, Dale J, et al. The acute sick and injured patients: an overview of the emergency department patient population at a Norwegian University Hospital Emergency Department. Eur J Emerg Med. 2014 Jun;21(3):175–180.
   PubMed Web of Science ®Google Scholar
• Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012 Feb 15;185(4):435–452.
   PubMed Web of Science ®Google Scholar
• Iyer S, Roughley A, Rider A, et al. The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study. Support Care Cancer. 2014 Jan;22(1):181–187.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Ferrer J, Baró E, et al. Differences between physician and patient in the perception of symptoms and their severity in COPD. Respir med. 2013;107(12):1977–1985.
   PubMed Web of Science ®Google Scholar
• Kochovska S, Chang S, Morgan DD, et al. Activities forgone because of chronic breathlessness: a cross-sectional population prevalence study. Palliative Med Rep. 2020;1(1):166–170.
   PubMedGoogle Scholar
• Kochovska S, Currow D, Chang S, et al. Persisting breathlessness and activities reduced or ceased: a population study in older men. BMJ Open Respir Res. 2022 May;9(1):e001168.
   PubMed Web of Science ®Google Scholar
• Lewthwaite H, Koch EM, Tracey L, et al. Standardized measurement of breathlessness during exercise. Curr Opin Support Palliat Care. 2019 Sep;13(3):152–160.
   PubMed Web of Science ®Google Scholar
• White KM, Agar MR, Currow DC. Assessing the exertion required to induce breathlessness in a population with advanced cancer: matching measures to the level of physical function. BMC Palliat Care. 2019 Jan 10;18(1):4.
   PubMedGoogle Scholar
• Koolen EH, van Hees HW, van Lummel RC, et al. “Can do” versus “do do”: a novel concept to better understand physical functioning in patients with chronic obstructive pulmonary disease. J Clin Med. 2019;8(3):340.
   PubMed Web of Science ®Google Scholar
• Schubert C, Archer G, Zelis JM, et al. Wearable devices can predict the outcome of standardized 6-minute walk tests in heart disease. npj Digital Med. 2020;3(1):1–9.
   PubMed Web of Science ®Google Scholar
• Ferreira DH, Ekström M, Verberkt C, et al. Is being able to walk to the letterbox life-changing? A qualitative assessment of measures of improvement in persistent breathlessness. ERJ Open Res. 2022;00530–2022.
   Google Scholar
• Glaab T, Vogelmeier C, Buhl R. Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res. 2010;11(1):1–11.
   PubMedGoogle Scholar
• Wilcock A, Crosby V, Clarke D, et al. Repeatability of breathlessness measurements in cancer patients. Thorax. 1999;54(4):374.
   PubMed Web of Science ®Google Scholar
• Gift AG, Narsavage G. Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care. 1998;7(3):200–204.
   PubMedGoogle Scholar
• Johnson MJ, Bland JM, Oxberry SG, et al. Clinically important differences in the intensity of chronic refractory breathlessness. J Pain Symptom Manage. 2013 Dec;46(6):957–963.
   PubMed Web of Science ®Google Scholar
• Johnson MJ, Close L, Gillon SC, et al. Use of the modified Borg scale and numerical rating scale to measure chronic breathlessness: a pooled data analysis. Eur Respir J. 2016 Jun;47(6):1861–1864.
   PubMed Web of Science ®Google Scholar
• Wade J, Mendonca S, Booth S, et al. Are within-person Numerical Rating Scale (NRS) ratings of breathlessness ‘on average’valid in advanced disease for patients and for patients’ informal carers? BMJ Open Respir Res. 2017;4(1):e000235.
   PubMed Web of Science ®Google Scholar
• Ekström M, Williams M, Johnson MJ, et al. Agreement between breathlessness severity and unpleasantness in people with chronic breathlessness: a longitudinal clinical study. J Pain Symptom Manage. 2019;57(4):715–723. e5.
   PubMed Web of Science ®Google Scholar
• Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exercise. 1982;14(5):377–381.
   PubMed Web of Science ®Google Scholar
• Lewthwaite H, Jensen D, Ekström M. How to assess breathlessness in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2021;16:1581.
   PubMed Web of Science ®Google Scholar
• Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD. 2005 Mar;2(1):105–110.
   PubMedGoogle Scholar
• Jones PW, Beeh KM, Chapman KR, et al. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med. 2014 Feb 1;189(3):250–255.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10):773–778.
   PubMed Web of Science ®Google Scholar
• Schünemann H, Goldstein R, Mador M, et al. A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire. Eur Respir J. 2005;25(1):31–40.
   PubMed Web of Science ®Google Scholar
• Jones P, Quirk F, Baveystock C. The St George’s Respiratory Questionnaire. Respir med. 1991;85:25–31. discussion 33.
   PubMed Web of Science ®Google Scholar
• Mahler DA, Weinberg DH, Wells CK, et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984 Jun;85(6):751–758.
   PubMed Web of Science ®Google Scholar
• Yorke J, Moosavi SH, Shuldham C, et al. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax. 2010;65(1):21–26.
   PubMed Web of Science ®Google Scholar
• Banzett RB, O’Donnell CR, Guilfoyle TE, et al. Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research. Eur Respir J. 2015;45(6):1681–1691.
   PubMed Web of Science ®Google Scholar
• Williams MT, Lewthwaite H, Paquet C, et al. Dyspnoea-12 and Multidimensional Dyspnea Profile: systematic Review of Use and Properties. J Pain Symptom Manage. 2022 Jan;63(1):e75–87.
   PubMed Web of Science ®Google Scholar
• Lewthwaite H, Jensen D. Tools for assessing complex breathlessness. In: James H Hull, Jemma H, editor. Complex Breathlessness (ERS Monograph) Sheffield. Eur Respir Soc. 2022;39–60.
   Google Scholar
• Currow DC, Ferreira DH. Palliative Management of Breathlessness. In: MacLeod RD, Van den Block L, editor. Textbook of Palliative Care. Cham: Springer International Publishing; 2019. p. 179–190.
   Google Scholar
• Campbell ML, Templin T, Walch J. A respiratory distress observation Scale for patients unable to self-report dyspnea. J Palliat Med. 2010 Mar;13(3):285–290.
   PubMed Web of Science ®Google Scholar
• Ahmadi Z, Sandberg J, Shannon-Honson A, et al. Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial. Eur Respir J. 2018;52(3).
   PubMed Web of Science ®Google Scholar
• Kochovska S, Chang S, Ferreira D, et al. Invisibility of breathlessness in clinical consultations: a cross-sectional, national online survey. Eur Respir J. 2022 Oct 6.
   Web of Science ®Google Scholar
• Celli B, Blasi F, Gaga M, et al. Perception of symptoms and quality of life - comparison of patients’ and physicians’ views in the COPD MIRROR study. Int J Chron Obstruct Pulmon Dis. 2017;12:2189–2196.
   PubMed Web of Science ®Google Scholar
• Currow DC, Clark K, Mitchell GK, et al. Prospectively collected characteristics of adult patients, their consultations and outcomes as they report breathlessness when presenting to general practice in Australia. PLoS ONE. 2013;8(9):e74814.
   PubMed Web of Science ®Google Scholar
• Chapple A, Ziebland S, McPherson A. Stigma, shame, and blame experienced by patients with lung cancer: qualitative study. BMJ. 2004 Jun 19;328(7454):1470.
   PubMedGoogle Scholar
• Hadjiphilippou S, Odogwu SE, Dand P. Doctors’ attitudes towards prescribing opioids for refractory dyspnoea: a single-centred study. BMJ Support Palliat Care. 2016;4(2):190–192.
   Google Scholar
• Lunn S, Dharmagunawardena R, Lander M, et al. It’s hard to talk about breathlessness: a unique insight from respiratory trainees. Clin Med. 2019;19(4):344.
   PubMed Web of Science ®Google Scholar
• Williams MT, Lewthwaite H, Brooks D, et al. Chronic breathlessness explanations and research priorities: findings from an international delphi survey. J Pain Symptom Manage. 2020 Feb;59(2):310–319 e12.
   PubMed Web of Science ®Google Scholar
• Marciniuk DD, Goodridge D, Hernandez P, et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J. 2011 Mar;18(2):69–78.
   PubMed Web of Science ®Google Scholar
• Rocker GM, Sinuff T, Horton R, et al. Advanced chronic obstructive pulmonary disease: innovative approaches to palliation. J Palliat Med. 2007;10(3):783–797.
   PubMed Web of Science ®Google Scholar
• Higginson IJ, Bausewein C, Reilly CC, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med. 2014;2(12):979–987.
   PubMed Web of Science ®Google Scholar
• Reilly CC, Bausewein C, Pannell C, et al. Patients’ experiences of a new integrated breathlessness support service for patients with refractory breathlessness: results of a postal survey. Palliat Med. 2016 Mar;30(3):313–322.
   PubMed Web of Science ®Google Scholar
• Smallwood N, Thompson M, Warrender-Sparkes M, et al. Integrated respiratory and palliative care may improve outcomes in advanced lung disease. ERJ Open Res. 2018;4(1):00102–2017.
   PubMedGoogle Scholar
• Yates P, Hardy J, Clavarino A, et al. A randomized controlled trial of a non-pharmacological intervention for cancer-related dyspnea. Front Oncol. 2020;10:591610.
   PubMed Web of Science ®Google Scholar
• Rueda JR, Sola I, Pascual A, et al. Non-invasive interventions for improving well-being and quality of life in patients with lung cancer. Cochrane Database Syst Rev. 2011 Sep;7(9). CD004282.
   PubMedGoogle Scholar
• Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64.
   PubMed Web of Science ®Google Scholar
• Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131(5):4S–42S.
   PubMed Web of Science ®Google Scholar
• McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2 2015.
   Web of Science ®Google Scholar
• Puhan MA, Gimeno‐santos E, Cates CJ, et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 12 2016.
   PubMedGoogle Scholar
• Dowman L, Hill CJ, May A, et al. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2021;(1).
   PubMedGoogle Scholar
• Shannon VR. Role of pulmonary rehabilitation in the management of patients with lung cancer. Curr Opin Pulm Med. 2010;16(4):334–339.
   PubMed Web of Science ®Google Scholar
• Alison JA, McKeough ZJ, Johnston K, et al. Australian and N ew Z ealand P ulmonary R ehabilitation G uidelines. Respirology. 2017;22(4):800–819.
   PubMed Web of Science ®Google Scholar
• Sibuya M, Yamada M, Kanamaru A, et al. Effect of chest wall vibration on dyspnea in patients with chronic respiratory disease. Am J Respir Crit Care Med. 1994;149(5):1235–1240.
   PubMed Web of Science ®Google Scholar
• Cristiano LM, Schwartzstein RM. Effect of chest wall vibration on dyspnea during hypercapnia and exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997 May;155(5):1552–1559.
   PubMed Web of Science ®Google Scholar
• Nakayama H, Shibuya M, Yamada M, et al. In-phase chest wall vibration decreases dyspnea during arm elevation in chronic obstructive pulmonary disease patients. Intern Med. 1998 Oct;37(10):831–835.
   PubMed Web of Science ®Google Scholar
• Lange DJ, Lechtzin N, Davey C, et al. High-frequency chest wall oscillation in ALS: an exploratory randomized, controlled trial. Neurology. 2006 Sep 26;67(6):991–997.
   PubMed Web of Science ®Google Scholar
• Rubin EM, Chapman GA, Eldridge M, et al. Effect of chest wall oscillation on mucus clearance: comparison of two vibrators. Pediatr Pulmonol. 1989;6(2):122–126.
   PubMed Web of Science ®Google Scholar
• Jones S, Man WD, Gao W, et al. Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. Cochrane Database Syst Rev. 2016 Oct 17;10. CD009419.
   Google Scholar
• Maddocks M, Nolan CM, Man WD, et al. Neuromuscular electrical stimulation to improve exercise capacity in patients with severe COPD: a randomised double-blind, placebo-controlled trial. Lancet Respir Med. 2016 Jan;4(1):27–36.
   PubMed Web of Science ®Google Scholar
• Bausewein C, Booth S, Gysels M, et al. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. 2008 Apr;16(2):CD005623.
   Google Scholar
• Hochstetter JK, Lewis J, Soares-Smith L. An investigation into the immediate impact of breathlessness management on the breathless patient: randomised controlled trial. Physiotherapy. 2005;91(3):178–185.
   Web of Science ®Google Scholar
• Wu X, Hou L, Bai W, et al. Effects of breathing training on quality of life and activities of daily living in elderly patients with stable severe chronic obstructive pulmonary disease. Chin J Rehabil Med. 2006;21(4):307–310.
   Google Scholar
• Probst VS, Troosters T, Coosemans I, et al. Mechanisms of improvement in exercise capacity using a rollator in patients with COPD. Chest. 2004;126(4):1102–1107.
   PubMed Web of Science ®Google Scholar
• Honeyman P, Barr P, Stubbing D. Effect of a walking aid on disability, oxygenation, and breathlessness in patients with chronic airflow limitation. J Cardiopulm Rehabil Prev. 1996;16(1):63–67.
   Google Scholar
• Dalton G, Ashley J, Rudkin S, et al. The effect of walking aids on walking distance, breathlessness and oxygenation in patients with severe chronic obstructive pulmonary disease (COPD). Thorax. 1995;50(suppl 2):A57.
   Google Scholar
• Gupta RB, Brooks D, Lacasse Y, et al. Effect of rollator use on health-related quality of life in individuals with COPD. Chest. 2006;130(4):1089–1095.
   PubMed Web of Science ®Google Scholar
• GOLD. Global strategy for the diagnosis, management, and pervention of chronic obstructive pulmonary disease. editor. Disease GIfCOL. Global Initiative for Chronic Obstructive Lung Disease, Inc. 2022.
   Google Scholar
• Uronis H, Currow DC, McCrory D, et al. Oxygen for relief of dyspnoea in mildly-or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. Br J Cancer. 2008;98(2):294–299.
   PubMed Web of Science ®Google Scholar
• Uronis HE, Ekström MP, Currow DC, et al. Oxygen for relief of dyspnoea in people with chronic obstructive pulmonary disease who would not qualify for home oxygen: a systematic review and meta-analysis. Thorax. 2015;70(5):492–494.
   PubMed Web of Science ®Google Scholar
• Alison JA, McKeough ZJ, Leung RWM, et al. Oxygen compared to air during exercise training in COPD with exercise-induced desaturation. Eur Respir J. 2019 May;53(5):1802429.
   Web of Science ®Google Scholar
• Abernethy AP, McDonald CF, Frith PA, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet. 2010 Sep 4;376(9743):784–793.
   PubMed Web of Science ®Google Scholar
• Moore RP, Berlowitz DJ, Denehy L, et al. A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax. 2011;66(1):32–37.
   PubMed Web of Science ®Google Scholar
• Hui D, Hernandez F, Urbauer D, et al. High‐flow oxygen and high‐flow air for dyspnea in hospitalized patients with cancer: a pilot crossover randomized clinical trial. Oncology. 2021;26(5):e883–892.
   Google Scholar
• Hui D, Morgado M, Chisholm G, et al. High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer: a phase II randomized trial. J Pain Symptom Manage. 2013;46(4):463–473.
   PubMed Web of Science ®Google Scholar
• Jaturapatporn D, Moran E, Obwanga C, et al. Patients’ experience of oxygen therapy and dyspnea: a qualitative study in home palliative care. Support Cancer Ther. 2010;18(6):765–770.
   PubMed Web of Science ®Google Scholar
• Landers A, Wiseman R, Pitama S, et al. Patient perceptions of severe COPD and transitions towards death: a qualitative study identifying milestones and developing key opportunities. NPJ Prim Care Respir Med. 2015;25(1):1–5.
   Google Scholar
• Kelly CA, Maden M. How do respiratory patients perceive oxygen therapy? A critical interpretative synthesis of the literature. Chron Respir Dis. 2014;11(4):209–228.
   PubMed Web of Science ®Google Scholar
• Lai Y, Chan CW, Lopez V. Perceptions of dyspnea and helpful interventions during the advanced stage of lung cancer: Chinese patients’ perspectives. Cancer Nurs. 2007;30(2):E1–8.
   PubMedGoogle Scholar
• Tanash HA, Ringbaek T, Huss F, et al. Burn injury during long-term oxygen therapy in Denmark and Sweden: the potential role of smoking. Int J Chron Obstruct Pulmon Dis. 2017;12:193.
   PubMed Web of Science ®Google Scholar
• Kochovska S, Ferreira DH, Garcia MV, et al. Perspectives on palliative oxygen for breathlessness: systematic review and meta-synthesis. Eur Respir J. 2021;58:2004613.
   PubMed Web of Science ®Google Scholar
• Swan F, Booth S. The role of airflow for the relief of chronic refractory breathlessness. Curr Opin Support Palliat Care. 2015 Sep;9(3):206–211.
   PubMed Web of Science ®Google Scholar
• Puspawati N, Sitorus R, Herawati T. Hand-held fan airflow stimulation relieves dyspnea in lung cancer patients. Asia Pac J Oncol Nurs. 2017 Apr;4(2):162–167.
   PubMed Web of Science ®Google Scholar
• Wong SL, Leong SM, Chan CM, et al. The effect of using an electric fan on dyspnea in Chinese patients with terminal cancer. Am J Hosp Palliat Care. 2017 Feb;34(1):42–46.
   PubMed Web of Science ®Google Scholar
• Barnes-Harris M, Allgar V, Booth S, et al. Battery operated fan and chronic breathlessness: does it help? BMJ Support Palliat Care. 2019 Dec;9(4):478–481.
   PubMed Web of Science ®Google Scholar
• Galbraith S, Fagan P, Perkins P, et al. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage. 2010 May;39(5):831–838.
   PubMed Web of Science ®Google Scholar
• Kako J, Morita T, Yamaguchi T, et al. Fan therapy is effective in relieving dyspnea in patients with terminally ill cancer: a parallel-arm, randomized controlled trial. J Pain Symptom Manage. 2018;56(4):493–500.
   PubMed Web of Science ®Google Scholar
• Kocatepe V. Lung cancer–related dyspnea: the effects of a handheld fan on management of symptoms. Clin J Oncol Nurs. 2021;25(6):655–661.
   PubMed Web of Science ®Google Scholar
• Long A, Cartwright M, Reilly CC. Impact of fan therapy during exercise on breathlessness and recovery time in patients with COPD: a pilot randomised controlled crossover trial. ERJ Open Res. 2021 Oct;7(4):00211–2021.
   PubMedGoogle Scholar
• Marchetti N, Lammi MR, Travaline JM, et al. Air current applied to the face improves exercise performance in patients with COPD. Lung. 2015 Oct;193(5):725–731.
   PubMed Web of Science ®Google Scholar
• Johnson MJ, Booth S, Currow DC, et al. A mixed-methods, randomized, controlled feasibility trial to inform the design of a phase III trial to test the effect of the handheld fan on physical activity and carer anxiety in patients with refractory breathlessness. J Pain Symptom Manage. 2016 May;51(5):807–815.
   PubMed Web of Science ®Google Scholar
• Kanezaki M, Terada K, Ebihara S. L-Menthol - a new treatment for breathlessness? Curr Opin Support Palliat Care. 2021 Dec 1;15(4):233–238.
   PubMed Web of Science ®Google Scholar
• Nishino T, Tagaito Y, Sakurai Y. Nasal inhalation of l-menthol reduces respiratory discomfort associated with loaded breathing. Am J Respir Crit Care Med. 1997;156(1):309–313.
   PubMed Web of Science ®Google Scholar
• Kanezaki M, Terada K, Ebihara S. Effect of olfactory stimulation by L-Menthol on Laboratory-Induced Dyspnea in COPD. Chest. 2020 Jun;157(6):1455–1465.
   PubMed Web of Science ®Google Scholar
• Prieur G, Beaumont M, Delorme M, et al. Short-term effects of menthol on walking dyspnoea in patients with COPD: a randomised, single blinded, cross-over study. ERJ Open Res. 2021;7(4):00450–2021.
   PubMedGoogle Scholar
• Plevkova J, Kollarik M, Poliacek I, et al. The role of trigeminal nasal TRPM8-expressing afferent neurons in the antitussive effects of menthol. J Appl Physiol (1985). 2013 Jul 15;115(2):268–274.
   PubMed Web of Science ®Google Scholar
• Eccles R, Griffiths DH, Newton CG, et al. The effects of menthol isomers on nasal sensation of airflow. Clin Otolaryngol Allied Sci. 1988 Feb;13(1):25–29.
   PubMed Web of Science ®Google Scholar
• Lightowler JV, Wedzicha JA, Elliott MW, et al. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ. 2003 Jan 25;326(7382):185.
   PubMedGoogle Scholar
• Winck JC, Azevedo LF, Costa-Pereira A, et al. Efficacy and safety of non-invasive ventilation in the treatment of acute cardiogenic pulmonary edema–a systematic review and meta-analysis. crit care. 2006;10(2):R69.
   PubMed Web of Science ®Google Scholar
• Cuomo A, Delmastro M, Ceriana P, et al. Noninvasive mechanical ventilation as a palliative treatment of acute respiratory failure in patients with end-stage solid cancer. Palliat Med. 2004;18(7):602–610.
   PubMed Web of Science ®Google Scholar
• Storgaard LH, Hockey H-U, Laursen BS, et al. Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int J Chron Obstruct Pulmon Dis. 2018;13:1195.
   PubMed Web of Science ®Google Scholar
• Huang J, Yuan X, Zhang N, et al. Music therapy in adults with COPD. Respir Care. 2021 Mar;66(3):501–509.
   PubMed Web of Science ®Google Scholar
• Mahler DA, Selecky PA, Harrod CG, et al. American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest. 2010 Mar;137(3):674–691.
   PubMed Web of Science ®Google Scholar
• Jennings A, Davies A, Higgins J, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57(11):939–944.
   PubMed Web of Science ®Google Scholar
• Ekstrom M, Nilsson F, Abernethy AA, et al. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc. 2015 Jul;12(7):1079–1092.
   PubMed Web of Science ®Google Scholar
• Ekstrom M, Bajwah S, Bland JM, et al. One evidence base; three stories: do opioids relieve chronic breathlessness? Thorax. 2018 Jan;73(1):88–90.
   PubMed Web of Science ®Google Scholar
• Johnson MJ, McDonagh TA, Harkness A, et al. Morphine for the relief of breathlessness in patients with chronic heart failure–a pilot study. Eur J Heart Fail. 2002 Dec;4(6):753–756.
   PubMed Web of Science ®Google Scholar
• Abernethy AP, Currow DC, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003 Sep 6;327(7414):523–528.
   PubMedGoogle Scholar
• Currow DC, McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage. 2011 Sep;42(3):388–399.
   PubMed Web of Science ®Google Scholar
• Portenoy RK, Southam MA, Gupta SK, et al. Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics. Anesthesiology. 1993 Jan;78(1):36–43.
   PubMed Web of Science ®Google Scholar
• Currow DC, Louw S, McCloud P, et al. Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial. Thorax. 2020 Jan;75(1):50–56.
   PubMed Web of Science ®Google Scholar
• Ekström M, Ferreira D, Chang S, et al. Effect of regular, low-dose, extended-release morphine on chronic breathlessness in chronic obstructive pulmonary disease: the beams randomized clinical trial. JAMA. 2022;328(20):2022–2032.
   PubMed Web of Science ®Google Scholar
• Verberkt CA, van den Beuken-van Everdingen MHJ, Schols J, et al. Effect of sustained-release morphine for refractory breathlessness in chronic obstructive pulmonary disease on health status: a randomized clinical trial. JAMA Intern Med. 2020 Oct 1;180(10):1306–1314.
   PubMed Web of Science ®Google Scholar
• Currow DC, Quinn S, Greene A, et al. The longitudinal pattern of response when morphine is used to treat chronic refractory dyspnea. J Palliat Med. 2013 Aug;16(8):881–886.
   PubMed Web of Science ®Google Scholar
• Ekström M, Elmberg V, Lindow T, et al. Breathlessness measurement should be standardised for the level of exertion. Eur Respir J. 2018;51(5):1800486.
   Google Scholar
• Rocker G, Young J, Donahue M, et al. Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease. CMAJ. 2012 Jun 12;184(9):E497–504.
   PubMed Web of Science ®Google Scholar
• Vozoris NT. Benzodiazepines and opioids need to be prescribed with caution in advanced COPD. Evid Based Med. 2014;19:170.
   PubMedGoogle Scholar
• Verberkt CA, van den Beuken-van MH, Schols JM, et al. Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis. Eur Respir J. 2017;50(5):1701153.
   PubMed Web of Science ®Google Scholar
• Vozoris NT, Wang X, Fischer HD, et al. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J. 2016 Sep;48(3):683–693.
   PubMed Web of Science ®Google Scholar
• Ferreira DH, Silva JP, Quinn S, et al. Blinded patient preference for morphine compared to placebo in the setting of chronic refractory breathlessness–an exploratory study. J Pain Symptom Manage. 2016 Feb;51(2):247–254.
   PubMed Web of Science ®Google Scholar
• Ferreira D. Regular, low-dose, sustained-release oral morphine for chronic breathlessness – Building the evidence. Bedford Park, South Australia, Australia: Flinders University; 2022.
   Google Scholar
• Ferreira DH, Ekström M, Sajkov D, et al. Extended-release morphine for chronic breathlessness in pulmonary arterial hypertension—a randomized, double-blind, placebo-controlled, crossover study. J Pain Symptom Manage. 2018;56(4):483–492.
   PubMed Web of Science ®Google Scholar
• Johnson MJ, Bland JM, Oxberry SG, et al. Opioids for chronic refractory breathlessness: patient predictors of beneficial response. Eur Respir J. 2013 Sep;42(3):758–766.
   PubMed Web of Science ®Google Scholar
• Ferreira DH, Louw S, McCloud P, et al. Controlled-release oxycodone vs. placebo in the treatment of chronic breathlessness-a multisite randomized placebo controlled trial. J Pain Symptom Manage. 2020 Mar;59(3):581–589.
   PubMed Web of Science ®Google Scholar
• Abdallah SJ, Wilkinson-Maitland C, Saad N, et al. Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial. Eur Respir J. 2017 Oct;50(4):1701235.
   PubMed Web of Science ®Google Scholar
• Verberkt CA, van den Beuken-Everdingen MHJ, Schols J, et al. Morphine for chronic breathlessness in COPD: improvement predictors-cross-sectional study. BMJ Support Palliat Care. 2022 Jul 18.
   Web of Science ®Google Scholar
• Abdallah SJ, Faull OK, Wanigasekera V, et al. Opioids for breathlessness: psychological and neural factors influencing response variability. Eur Respir J. 2019 Sep;54(3):1900275.
   PubMed Web of Science ®Google Scholar
• Currow DC, Quinn S, Ekstrom M, et al. Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors? BMJ Open. 2015 May 6;5(5):e006818.
   PubMed Web of Science ®Google Scholar
• Simon ST, Higginson IJ, Booth S, et al. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev. 2016 Oct 20;10. CD007354.
   PubMedGoogle Scholar
• Peoples AR, Bushunow PW, Garland SN, et al. Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study. Support Cancer Ther. 2016;24(3):1339–1347.
   PubMed Web of Science ®Google Scholar
• Eiser N, Harte R, Karvounis S, et al. Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD. 2005;2(2):233–241.
   PubMedGoogle Scholar
• Lacasse Y, Beaudoin L, Rousseau L, et al. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis. 2004;61(3).
   PubMedGoogle Scholar
• Currow DC, Ekström M, Louw S, et al. Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial. Eur Respir J. 2019;53(1):1801270.
   Web of Science ®Google Scholar
• Jensen D, Amjadi K, Harris-McAllister V, et al. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD. Thorax. 2008 Jul;63(7):606–613.
   PubMed Web of Science ®Google Scholar
• Vahedi H, Mahshidfar B, Rabiee H, et al. The adjunctive effect of nebulized furosemide in COPD exacerbation: a randomized controlled clinical trial. Respir Care. 2013 Nov;58(11):1873–1877.
   PubMed Web of Science ®Google Scholar
• Lockhart A, Slutsky AS. Furosemide and loop diuretics in human asthma. Chest. 1994;106(1):244–249.
   PubMed Web of Science ®Google Scholar
• Verleden G, Pype J, Deneffe G, et al. Effect of loop diuretics on cholinergic neurotransmission in human airways in vitro. Thorax. 1994;49(7):657–663.
   PubMed Web of Science ®Google Scholar
• Moosavi SH, Binks AP, Lansing RW, et al. Effect of inhaled furosemide on air hunger induced in healthy humans. Respir Physiol Neurobiol. 2007;156(1):1–8.
   PubMed Web of Science ®Google Scholar
• Newton PJ, Davidson PM, Krum H, et al. Acute hemodynamic effects of nebulised furosemide in stable heart failure. J Card Fail. 2009;15(6):S5.
   Web of Science ®Google Scholar